Qualified Participants Must:
• Be Men between 45 and 80 years age
•
Have previously documented low serum testosterone concentrations (<
• 300 ng/dL)
• Exhibit at least one sign or symptom of hypogonadism
• Have evidence of cardiovascular (CV) disease or are at an increased risk for CV disease
Qualified Participants May Receive:
Costs: Neither you nor your insurance company will have to pay for the study drug (AndroGel 1.62% or placebo) or procedures that are done only for the study.
Reimbursement and Payments: The IRB has also agreed that you may be paid $50.00 for each completed study visit, and $15.00 for each completed telephone visit. We may have to report this payment to the IRS if applicable.